American Journal of Preventive Medicine
Volume 20, Issue 2 , Pages 130-134 , February 2001

Physician–patient discussions of controversial cancer screening tests1

Presented in part at the Society of General Internal Medicine Annual National Meeting, April 29 to May 1, 1999, San Francisco, California.

  • Andrew S Dunn, MD

      Affiliations

    • Departments of Medicine (Dunn, Shridharani, Horowitz, Bernstein), Mount Sinai School of Medicine, New York, New York, USA
    • Corresponding Author InformationAddress correspondence and reprint requests to: Andrew Dunn, MD, 1470 Madison Ave, Box 1087, Mount Sinai Medical Center, New York, NY 10029
    • ,
  • Kanan V Shridharani, MD

      Affiliations

    • Departments of Medicine (Dunn, Shridharani, Horowitz, Bernstein), Mount Sinai School of Medicine, New York, New York, USA
    • ,
  • Wendy Lou, PhD

      Affiliations

    • Biomathematical Sciences (Lou), Mount Sinai School of Medicine, New York, New York, USA
    • ,
  • Jeffrey Bernstein, MD

      Affiliations

    • Departments of Medicine (Dunn, Shridharani, Horowitz, Bernstein), Mount Sinai School of Medicine, New York, New York, USA
    • ,
  • Carol R Horowitz, MD, MPH

      Affiliations

    • Departments of Medicine (Dunn, Shridharani, Horowitz, Bernstein), Mount Sinai School of Medicine, New York, New York, USA
    • Health Policy (Horowitz), Mount Sinai School of Medicine, New York, New York, USA

References 

  1. Ubel PA. Informed consent (from bodily invasion to the seemingly mundane). Arch Int Med. 1996;156:1262–1263
  2. Kessel AS. On failing to understand informed consent. Br J Hosp Med. 1994;52:235–238
  3. President’s Commission for the Study of Ethical Problems in Medicine and Biomedical Research and Behavioral Research. The ethical and legal implications of informed consent in the patient-practitioner relationship. Washington, DC: U.S. Government Printing Office, 1982.
  4. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter (what does it mean?). Soc Sci Med. 1997;44:681–692
  5. Marshall KG. Prevention. How much harm? How much benefit? The ethics of informed consent for preventive screening programs. Can Med Assoc. 1996;155:377–383
  6. Brett AS. The mammography and prostate-specific antigen controversies (implications for patient-physician encounters and public policy). J Gen Intern Med. 1995;10:266–270
  7. Wolf AMD, Becker DM. Cancer screening and informed patient discussions (truth and consequences). Arch Intern Med. 1996;156:1069–1072
  8. Atkins D. Improving screening for cancer in the primary care setting. Where do we need to go and how can we get there?. J Gen Intern Med. 1994;151:563–564
  9. Skrabanek P. Why is preventive medicine exempted from ethical constraints?. J Med Ethics. 1990;16:187–190
  10. U.S. Preventive Services Task Force . Guide to clinical preventive services, 2nd ed. Baltimore, MD: Williams & Wilkins; 1996;
  11. Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Ottawa, Canada: Canadian Communication Group, 1994.
  12. Catalona WJ. Management of cancer of the prostate. N Eng J Med. 1994;331:996–1004
  13. Coley CM, Barry MJ, Mulley AG. The American College of Physicians. Clinical guideline (part III, screening for prostate cancer). Ann Intern Med. 1997;126:480–484
  14. Mettlin C. Defining and updating the American Cancer Society guidelines for the cancer-related checkup (prostate and endometrial cancers). CA Cancer J Clin. 1993;43:42–46
  15. Von Eschenbach A, Ho R, Murphy GP, Cunningham M, Lins M. American Cancer Society guideline for the early detection of prostate cancer (update 1997). CA Cancer J Clin. 1997;47:261–264
  16. Eddy DM. Screening for breast cancer. Ann Intern Med. 1989;111:389–399
  17. Baines CJ. Women and breast cancer (is it really possible for the public to be well informed?). Can Med Assoc J. 1992;146:2147–2148
  18. Kuni CC. Mammography in the 1990s (a plea for objective doctors and informed patients). Am J Prev Med. 1993;9:185–190
  19. Pauker SG, Kassirer JP. Contentious screening decisions (does the choice matter?). New Eng J Med. 1997;336:1243–1244
  20. Harris R, Leninger L. Clinical strategies for breast cancer screening (weighing and using the evidence). Ann Intern Med. 1995;122:539–547
  21. Rimer BK. Putting the “informed” in informed consent about mammography. J Natl Cancer Inst. 1995;87:703–704
  22. Sox HC. Screening mammography in women younger than 50 years of age. Ann Intern Med. 1995;122:550–552
  23. Ransohoff DF, Harris RP. Lessons from the mammography screening controversy (can we improve the debate?). Ann Intern Med. 1997;127:1029–1034
  24. Gerber GS, Chodak GW. Early diagnosis of prostate cancer. In:  DeVita VT,  Hellman S,  Rosenberg SA editor. Important advances in oncology. Philadelphia, PA: J.B. Lippincott Company; 1993;p. 93–101
  25. Chodak GW. Screening for prostate cancer (the debate continues). JAMA. 1994;272:813–814
  26. Marshall KG. Screening for prostate cancer (how can patients give informed consent?). Can Fam Phys. 1993;39:2385–2390
  27. Woolf SH. Screening for prostate cancer with prostate-specific antigen (an examination of the evidence). N Eng J Med. 1995;333:1401–1405
  28. Quill TE, Brody DS. Physician recommendations and patient autonomy (finding a balance between physician power and patient choice). Ann Intern Med. 1996;125:763–769
  29. Brody DS. The patient’s role in clinical decision making. Ann Intern Med. 1980;93:718–722
  30. Deber RB. Physicians in health care management (7. The patient-physician partnership: changing roles and the desire for information). Can Med Assoc J. 1994;151:171–176
  31. Liss D. So much to do, so little time. J Gen Intern Med. 1989;12:135–136
  32. Flood AB, Wennberg JE, Nease RF, Fowler FJ, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. J Gen Intern Med 196;11:342–9.
  33. Waitzkin H. Doctor-patient communication (clinical implications of social scientific research). JAMA. 1984;252:2441–2446
  34. Siminoff LA, Fetting JH, Abeloff MD. Doctor-patient communication about breast cancer adjuvant therapy. J Clin Oncol. 1989;7:192–200
  35. Makoul G, Arntson P, Schofield T. Health promotion in primary care (physician-patient communication and decision making about prescription medications). Soc Sci Med. 1995;41:1241–1254
  36. Braddock CH, Fihn SD, Levinson W, Jonsen AR, Pearlman RA. How doctors and patients discuss routine clinical decisions (informed decision making in the outpatient setting). J Gen Intern Med. 1997;12:339–345

PII: S0749-3797(00)00288-9

American Journal of Preventive Medicine
Volume 20, Issue 2 , Pages 130-134 , February 2001

Article Tools